US · Healthcare · Medical Instruments & Supplies
EPS came in at 1.76 against a street estimate of 1.28 — a beat of 37.5%.
Analysts rate Teleflex Incorporated a hold (2 buy, 11 hold, 1 sell out of 14) with an average price target of $153.55.
MIXED Q2 beat expectations with 4.7% organic growth and $1.76 adjusted EPS. BIOTRONIK integration delays extended through H2 2026; revenue guide cut to 3.5–4.5%. EZPlaz FDA approval and Freesolve progress boost innovation pipeline. Q2 2026 Call focused on product lines, not geographies. No regional breakdowns provided. Analysts pressed on VI integration details, BIOTRONIK confidence by year-end, and 2027 EPS trajectory. Weidman detailed three transient operational headwinds (order-to-cash, distributor, sales force) and signaled no step-change in 2027—only ramp-up. CFO confirmed analyst EPS modeling (~$11.25–$11.50) 'doesn't sound unreasonable' given 23% target margin and capital deployment tailwinds. 2026-08-06…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 12.73% |
| HHG PLC | 10.13% |
| T. Rowe Price Investment Management,Inc. | 9.05% |
| Vanguard Portfolio Management, LLC | 5.75% |
| Vanguard Capital Management, LLC | 4.68% |
| Sessa Capital, L.P | 3.60% |
| State Street Corp | 3.55% |
| Millennium Management LLC | 3.40% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 TELEFLEX INCORPORATED - FORM 8-K SUMMARY HEADLINE NUMBERS • Board size increased from 8 to 9 directors on September 8, 2026 • One new director appoi | 2026-09-09 |
| Company announcement · Q3 2026 TELEFLEX INCORPORATED – FORM 8-K SUMMARY HEADLINE NUMBERS • Accelerated Share Repurchase (ASR) Transaction: $250 million repurchase program entered | 2026-08-07 |
| Quarterly report · Q2 2026 TELEFLEX INCORPORATED — Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Q2 2026 Net revenues (continuing operations): $570.3 million vs. $442.5 million in Q | 2026-08-06 |
| Results announced · Q3 2026 TELEFLEX INCORPORATED – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 continuing operations revenue: $570.3 million, up 28.9% reported / up 4. | 2026-08-06 |
| Acquisition completed · Q3 2026 TELEFLEX INCORPORATED – FORM 8-K SUMMARY HEADLINE NUMBERS • Completed sale of Original Equipment Manufacturing and Development Services business (OE | 2026-08-03 |
| Material agreement · Q2 2026 TELEFLEX INCORPORATED – 8-K SUMMARY HEADLINE NUMBERS • Company issued $500,000,000 in senior notes on June 15, 2026 • Interest rate: 5.875% per year | 2026-06-15 |
| Quarterly report · Q1 2026 TELEFLEX INCORPORATED – Q1 2026 FORM 10-Q SUMMARY HEADLINE NUMBERS • Net revenues (continuing operations): $548.3 million, up 32% vs. $414.3 million | 2026-05-07 |
| Proxy statement · Q2 2026 TELEFLEX INCORPORATED PROXY SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Vote 1 (Election of Directors): Elect seven directors for one-year terms: Cand | 2026-04-13 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.34 / share ex-date Aug 14, 2026 · pay Sep 30, 2026 | 2026-08-14 |
| Dividend | $0.34 / share ex-date May 22, 2026 · pay Jun 30, 2026 | 2026-05-22 |
| Dividend | $0.34 / share ex-date Mar 6, 2026 · pay Mar 31, 2026 | 2026-03-06 |
| Dividend | $0.34 / share ex-date Nov 14, 2025 · pay Dec 15, 2025 | 2025-11-14 |
| Dividend | $0.34 / share ex-date Aug 15, 2025 · pay Sep 15, 2025 | 2025-08-15 |
| Announcement | Date |
|---|---|
| Accelerated share repurchase program of $250 million announced On August 7, 2026, Teleflex Incorporated announced an accelerated share repurchase (ASR) program with Truist Bank to buy back $250 million of its own stock. This is part of the company's bro | 2026-08-07 |
| HSR approval obtained for OEM divestiture transaction; FTC second request on urology sale Teleflex is selling off two business divisions through separate transactions announced in December 2025. The first sale of its OEM (Original Equipment Manufacturing) and development services | 2026-03-17 |
| Company acquires businesses through equity purchase agreements announced The company announced two asset sales (referred to as 'the Transactions') on December 9, 2025, and authorized a $1 billion share repurchase program funded by proceeds from these sales. The c | 2025-12-09 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Teleflex Incorporated — free to start.
Google PlayApp StoreData updated 2026-09-18.